ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021

NEXT STORY
OraSure Awarded $109 Million Contract from U.S. Department of Defense to Ramp Manufacturing of InteliSwab™ COVID-19 Rapid Test
PREV STORY
Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kite Pharma and Leiden University Medical Center Sign Research and License Agreement for T Cell Receptors Targeting HPV-Associated Cancers

SANTA MONICA, Calif., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today ...

author_avatar
NASDAQ Market News

ZH Healthcare announces blueEHR collaboration with Sanford Health to enable global healthcare

MCLEAN, Va., Sept. 18, 2017 (GLOBE NEWSWIRE) -- ZH Healthcare announced that blueEHR, the company’s customizable eHealth ...

author_avatar
NASDAQ Market News

Samumed Announces Results of Phase 2 Trial of SM04690 Demonstrating Evidence of Cartilage Regeneration in Patients with Knee Osteoarthritis

- Data support potential of SM04690 as a disease modifying drug for knee osteoarthritis ...

author_avatar
NASDAQ Market News